These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9798200)

  • 21. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapeutic treatment of prostatic carcinoma with pelvic node involvement.
    Bagshaw MA
    Urol Clin North Am; 1984 May; 11(2):297-304. PubMed ID: 6428023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of pelvic lymphadenectomy for prostate cancer--therapeutic?
    Wagner M; Sokoloff M; Daneshmand S
    J Urol; 2008 Feb; 179(2):408-13. PubMed ID: 18076938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.
    Lawton CA; Winter K; Grignon D; Pilepich MV
    J Clin Oncol; 2005 Feb; 23(4):800-7. PubMed ID: 15681524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-pelvic nodal radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: a step forward.
    Kaidar-Person O; Roach M; Créhange G
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):600-5. PubMed ID: 23523182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum.
    Briganti A; Suardi N; Capogrosso P; Passoni N; Freschi M; di Trapani E; Gallina A; Capitanio U; Abdollah F; Tutolo M; Bianchi M; Salonia A; Da Pozzo LF; Montorsi F; Rigatti P
    Prostate; 2012 Feb; 72(2):186-92. PubMed ID: 21538428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation Therapy Oncology Group studies in carcinoma of the prostate.
    Pilepich MV
    NCI Monogr; 1988; (7):61-5. PubMed ID: 3173504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.
    Messing EM; Manola J; Yao J; Kiernan M; Crawford D; Wilding G; di'SantAgnese PA; Trump D;
    Lancet Oncol; 2006 Jun; 7(6):472-9. PubMed ID: 16750497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement.
    Jacob R; Hanlon AL; Horwitz EM; Movsas B; Uzzo RG; Pollack A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):695-701. PubMed ID: 15708247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of radiotherapy on node-positive prostate cancer treated with androgen ablation.
    Sands ME; Pollack A; Zagars GK
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):13-9. PubMed ID: 7527796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma.
    Aizer AA; Yu JB; McKeon AM; Decker RH; Colberg JW; Peschel RE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1344-9. PubMed ID: 19464821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pelvic node dissection in prostate cancer: extended, limited, or not at all?
    Hyndman ME; Mullins JK; Pavlovich CP
    Curr Opin Urol; 2010 May; 20(3):211-7. PubMed ID: 20224412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of three strategies in management of independent movement of the prostate and pelvic lymph nodes.
    Xia P; Qi P; Hwang A; Kinsey E; Pouliot J; Roach M
    Med Phys; 2010 Sep; 37(9):5006-13. PubMed ID: 20964220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
    Fodor J; Polgár C; Németh G
    Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
    Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique.
    Ganswindt U; Paulsen F; Corvin S; Hundt I; Alber M; Frey B; Stenzl A; Bares R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):347-55. PubMed ID: 17236960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Locally advanced prostate cancer: definition, prognosis and treatment].
    Plantade A; Massard C; de Crevoisier R; Fizazi K
    Bull Cancer; 2007 Jul; 94(7 Suppl):F50-61. PubMed ID: 17845994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult pelvic lymph node involvement in bladder cancer: implications for definitive radiation.
    Goldsmith B; Baumann BC; He J; Tucker K; Bekelman J; Deville C; Vapiwala N; Vaughn D; Keefe SM; Guzzo T; Malkowicz SB; Christodouleas JP
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):603-10. PubMed ID: 24411628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of prostate carcinoma. Combination of pelvic lymphadenectomy, temporary Ir-192 implantation, and external irradiation.
    Syed AM; Puthawala A; Tansey LA; Shanberg AM; Neblett D; Mendez R; Barloon JW; Ingram JE; Naftel WT; McNamara C
    Radiology; 1983 Dec; 149(3):829-33. PubMed ID: 6417724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating hormonal therapy with external-beam radiation and brachytherapy for prostate cancer.
    Andrews J; Roach M
    Oncology (Williston Park); 2005 Jan; 19(1):29-36; discussion 36, 39, 43-4. PubMed ID: 15743150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.